Biomarkers UK

Biomarkers UK 2022

Biognosys will be attending Biomarkers UK on May 3-4 in London, UK. You can find us at booth #38. Do not miss the oral presentation on May 3 at 12:30 pm (GMT+1) by our Director of Scientific Alliances, Yuehan Feng.

Oral presentation

An Integrated MS Proteomics Platform from Biomarker Discovery to Customized Assay Panelsheld

  • State-of-the-art mass spectrometry platform for unbiased biomarker discovery and development of customized assay panels across various biological specimen
  • Sub-protein resolution allows quantification of proteoforms such as post-translational modifications, isoforms, and mutations
  • Discovery of biomarker signatures through quantitative profiling of paired CSF-plasma samples from an Alzheimer’s Disease cohort

 

Yuehan Feng, Ph.D.
Director of Scientific Alliances
(Biognosys)

External oral presentation

Using A Dual Proteomics And Multiplexed IF Approach For The Detection Of Biomarkers Predictive For Response To ICI-Therapy

  • Identification of over 70 proteins differentially regulated in melanoma patients responding to therapy
  • Several immune phenotypes, including T cell subsets and M1 TAMs, significantly increased in responders

 

Anna Juncker-Jensen
Principal Scientist
(NeoGenomics)

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    SpectroDive™ 11

    Straightforward Validation
    of Your Protein Targets

    New: SpectroDive™ 11

    Straightforward Validation of Your Protein Targets

    learn more